Scientist Cell Biology
MSci in Biomedical Science (2012-2017), University of Aberdeen
Doctor of Philosophy (2017-2022), MRC PPU, University of Dundee
Luke joined the Ciulli group as a Cell Biologist as part of the PROTAC Drug Discovery collaboration with Boehringer Ingelheim. Previously, Luke completed his MSci in Biomedical Science at the University of Aberdeen and his PhD under the supervision of Professor Gopal Sapkota and Dr Ian Ganley in the MRC PPU at the University of Dundee. Here, Luke’s doctoral research centred around exploring technologies for targeted protein modification and involved the combined use of nanobody- and PROTAC-based technologies for targeted protein degradation. Outside of the lab, Luke enjoys dabbling in baking/cooking, exploring the outdoors, and going to gigs for a wee boogie.